Besides, a study on 17 patients with AML and a human AML cell line, and THP-1, demonstrated that despite the high NF-κB expression in AML patients, inhibition of this factor (with BAY 11–7082) did not significantly increase the rate of apoptosis. Here, NFKB1 is linked to acute myeloid leukemia.